Blended Coronary Revascularization with Drug-Coated Balloon and Drug-Eluting Stent: A Narrative Review on Rationale, Clinical Evidence, and Future Perspectives.

J Clin Med · 2025 · PMC12610358 · PMID 41226975

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

showed a trendp = 0.09so close (0.05 < p ≤ 0.1)

A meta-analysis from our group including five observational studies with 2.087 patients (mean follow-up 32 months) showed a trend toward lower rates of target vessel failure (0.45% vs. 0.76% person-months; p = 0.09) and cardiac death (0.05% vs. 0.10% person-months; p = 0.09) [ 15 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.